Key differences between triptans relate to their pharmacokinetic profiles and available formulations

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.3, 2011-03, pp. : 15-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Newer Formulations of the Triptans: Advances in Migraine Management

By Gladstone J.P. Gawel M.

Drugs, Vol. 63, Iss. 21, 2003-01 ,pp. : 2285-2305

Adis International

Access to resources Recommend Favorite

Variation of Pharmacokinetic Profiles of Some Antidiabetic Drugs from Nanostructured Formulations Administered Through Pulmonary Route

Current Drug Metabolism, Vol. 17, Iss. 3, 2016-03 ,pp. : 271-278

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor

By Giorgi Mariano A Cohen Arazi Hernáán Gonzalez Claudio D Di Girolamo Guillermo

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1285-1295

Informa Healthcare

Access to resources Recommend Favorite

A study of the pharmacodynamic differences between immediate and extended release bumetanide formulations

By Hamed E. Gerson M.C. Millard R.W. Sakr A.

International Journal of Pharmaceutics, Vol. 267, Iss. 1, 2003-11 ,pp. : 129-140

Elsevier

Access to resources Recommend Favorite

Second-Generation Antipsychotics: Is There Evidence for Sex Differences in Pharmacokinetic and Adverse Effect Profiles?

By Aichhorn Wolfgang Whitworth Alexandra B. Weiss Elisabeth M. Marksteiner Josef

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 587-598

Adis International

Access to resources Recommend Favorite